Pharmaceuticals  

Benjamin Warner, CEO.

Warner developed XRpro® Technology and founded Caldera Pharmaceuticals. He has a background in chemical synthesis and molecular recognition. He holds a PhD from the Massachusetts Institute of Technology.

email: warner@CPsci.com

Lori Peterson, COO.

Peterson is a molecular and genetic epidemiologist who previously worked at the National Institutes of Health ~ National Cancer Institute, the American Cancer Society HQ, the Centers for Disease Control and Prevention, MD Anderson, and Fred Hutchinson Cancer Center. She has a background in disease etiology and prevention. She holds an MS in Molecular Genetics from Texas A&M, MPH in Cancer Epidemiology from the University of Washington and PhD training in Environmental Medicine from the University of Texas in Houston.

email: peterson@CPsci.com

XRpro® drug discovery technology

Caldera pioneered high-throughput, label-free XRpro® drug discovery technology. XRpro® allows the screening of tens of thousands of protein-drug interactions per day with no modifications to either the drug candidate or the protein/target.

XRpro® eliminates costly and error-inducing chemical labels and provides data that more closely approximates in vivo drug behavior.